Literature DB >> 12777386

High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway.

Sean Shaw1, Xiaodan Wang, Heather Redd, Gwendolyn D Alexander, Carlos M Isales, Mario B Marrero.   

Abstract

Angiotensin II (Ang II), protein kinase C (PKC), reactive oxygen species (ROS) generated by NADPH oxidase, the activation of Janus kinase 2 (JAK2), and the polyol pathway play important parts in the hyperproliferation of vascular smooth muscle cells (VSMC), a characteristic feature of diabetic macroangiopathy. The precise mechanism, however, remains unclear. This study investigated the relation between the polyol pathway, PKC-beta, ROS, JAK2, and Ang II in the development of diabetic macroangiopathy. VSMC cultured in high glucose (HG; 25 mm) showed significant increases in the tyrosine phosphorylation of JAK2, production of ROS, and proliferation activities when compared with VSMC cultured in normal glucose (5.5 mm (NG)). Both the aldose reductase specific inhibitor (zopolrestat) or transfection with aldose reductase antisense oligonucleotide blocked the phosphorylation of JAK2, the production of ROS, and proliferation of VSMC induced by HG, but it had no effect on the Ang II-induced activation of these parameters in both NG and HG. However, transfection with PKC-beta antisense oligonucleotide, preincubation with a PKC-beta-specific inhibitor (LY379196) or apocynin (NADPH oxidase-specific inhibitor), or electroporation of NADPH oxidase antibodies blocked the Ang II-induced JAK2 phosphorylation, production of ROS, and proliferation of VSMC in both NG and HG. These observations suggest that the polyol pathway hyperactivity induced by HG contributes to the development of diabetic macroangiopathy through a PKC-beta-ROS activation of JAK2.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12777386     DOI: 10.1074/jbc.M305008200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.

Authors:  Mariane Abdillahi; Radha Ananthakrishnan; Srinivasan Vedantham; Linshan Shang; Zhengbin Zhu; Rosa Rosario; Hylde Zirpoli; Kurt M Bohren; Kenneth H Gabbay; Ravichandran Ramasamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-01       Impact factor: 4.733

Review 2.  The role of Src homology 2 containing protein tyrosine phosphatase 2 in vascular smooth muscle cell migration and proliferation.

Authors:  Machender R Kandadi; Matthew S Stratton; Jun Ren
Journal:  Acta Pharmacol Sin       Date:  2010-09-27       Impact factor: 6.150

Review 3.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

4.  Myocardial Hypertrophic Remodeling and Impaired Left Ventricular Function in Mice with a Cardiac-Specific Deletion of Janus Kinase 2.

Authors:  Xiaohong T Gan; Venkatesh Rajapurohitam; Jenny Xue; Cathy Huang; Suresh Bairwa; Xilan Tang; Jeffrey T-Y Chow; Melissa F W Liu; Felix Chiu; Kazuhito Sakamoto; Kay-Uwe Wagner; Morris Karmazyn
Journal:  Am J Pathol       Date:  2015-12       Impact factor: 4.307

5.  Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway.

Authors:  Yu-min Liu; Xiong Wang; Ahmed Nawaz; Zhao-hong Kong; Yan Hong; Chang-hua Wang; Jun-jian Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

Review 6.  Targeting Select Cellular Stress Pathways to Prevent Hyperglycemia-Related Complications: Shifting the Paradigm.

Authors:  Arshag D Mooradian
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

7.  Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species.

Authors:  Annet Kirabo; Patrick N Kearns; Yagna P Jarajapu; Jennifer M Sasser; Suk Paul Oh; Maria B Grant; Hideko Kasahara; Arturo J Cardounel; Chris Baylis; Kay-Uwe Wagner; Peter P Sayeski
Journal:  Cardiovasc Res       Date:  2011-02-24       Impact factor: 10.787

Review 8.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

9.  Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.

Authors:  Umesh C S Yadav; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

10.  The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure.

Authors:  Christophe Guilluy; Jérémy Brégeon; Gilles Toumaniantz; Malvyne Rolli-Derkinderen; Kevin Retailleau; Laurent Loufrani; Daniel Henrion; Elizabeth Scalbert; Antoine Bril; Raul M Torres; Stephan Offermanns; Pierre Pacaud; Gervaise Loirand
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.